Consensus Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
6.56 ^USD	+0.46%		+19.49%	+47.09%

20/06	Ocular Therapeutix Shares Rise After TD Cowen Upgrades Rating, Increases Price Target	MT
20/06	TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7	MT

Evolution of the average Target Price on Ocular Therapeutix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7a6d55.BX5-9JDdG3tAaXGMi9PUfJVTcnd19YLjWcNj0CyJ8v0.MxQGsva8Igt5EDzP-KGcDKYfR1olj_WKNI0wlW_No5t9SRCY47x4TRksFg~289e2b8e98fa99a5b57e0f141b67f6fa

Analyst Recommendations on Ocular Therapeutix, Inc.

TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7	20/06	MT
Piper Sandler Starts Ocular Therapeutix With Overweight Rating, $15 Price Target	31/05	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $15 From $12, Keeps Buy Rating	13/03	MT
TD Cowen Adjusts Price Target on Ocular Therapeutix to $11 From $8, Maintains Market Perform Rating	12/03	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $24 From $12, Maintains Market Outperform Rating	12/03	MT
Piper Sandler Adjusts Ocular Therapeutix Price Target to $15 From $10, Maintains Overweight Rating	26/02	MT
HC Wainwright Adjusts Ocular Therapeutix Price Target to $12 From $10, Maintains Buy Rating	13/23/13	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $11, Maintains Buy Rating	09/23/09	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $12 From $11, Keeps Market Outperform Rating	09/23/09	MT
Baird Initiates Ocular Therapeutix at Outperform With $18 Price Target	21/23/21	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $11 From $12, Maintains Market Outperform Rating	07/23/07	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $11 From $9, Maintains Buy Rating	14/23/14	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix's to $12 From $25, Maintains Market Outperform Rating	09/23/09	MT
Raymond James Adjusts Price Target on Ocular Therapeutix to $14 From $29, Maintains Strong Buy Rating	08/22/08	MT
HC Wainwright Trims Price Target on Ocular Therapeutix to $9 From $10, Maintains Buy Rating	08/22/08	MT
Berenberg Bank Assumes Coverage on Ocular Therapeutix With Buy Rating, $15 Price Target	10/22/10	MT
JMP Securities Adjusts Ocular Therapeutix Price Target to $25 From $20, Maintains Market Outperform Rating	09/22/09	MT
Jefferies Raises Price Target for Ocular Therapeutix to $6.50 From $5, Maintains Buy Rating	09/22/09	MT
Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors	01/22/01	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $10 From $16, Reiterates Overweight Rating	31/22/31	MT
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating	11/22/11	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating	10/22/10	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Overweight Rating	10/22/10	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $22 from $30, Keeps Market Outperform Rating	01/22/01	MT
Berenberg Bank Adjusts Price Target on Ocular Therapeutix to $23 From $26, Maintains Buy Rating	10/21/10	MT